Guangzhou Xiling Biotechnology Co., Ltd.

This early-stage study tests a new drug called CEL001 injection in 13 people with advanced solid tumors that have not responded to standard treatments. The main goal is to check if the injection is safe and tolerable. Researchers will also look for signs that the drug might shrin…